Sintilimab Active Not Recruiting Phase 3 Trials for Esophageal Squamous Cell Carcinoma (ESCC) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05495152Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma